Format

Send to

Choose Destination
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53.

Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.

Author information

1
Servicio de Microbiología, Hospital Universitario Ramón y Cajal, Madrid, Spain. rcanton.hrc@salud.madrid.org

Erratum in

  • Clin Microbiol Infect. 2008 May;14 Suppl 5:21-4.

Abstract

Extended-spectrum beta-lactamases (ESBLs) represent a major threat among resistant bacterial isolates. The first types described were derivatives of the TEM-1, TEM-2 and SHV-1 enzymes during the 1980s in Europe, mainly in Klebsiella pneumoniae associated with nosocomial outbreaks. Nowadays, they are mostly found among Escherichia coli isolates in community-acquired infections, with an increasing occurrence of CTX-M enzymes. The prevalence of ESBLs in Europe is higher than in the USA but lower than in Asia and South America. However, important differences among European countries have been observed. Spread of mobile genetic elements, mainly epidemic plasmids, and the dispersion of specific clones have been responsible for the increase in ESBL-producing isolates, such as those with TEM-4, TEM-24, TEM-52, SHV-12, CTX-M-9, CTX-M-14, CTX-M-3, CTX-M-15 and CTX-M-32 enzymes.

[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center